- 专利标题： LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME
-
申请号： EP20194167.1申请日： 2016-02-12
-
公开(公告)号： EP3778605A2公开(公告)日： 2021-02-17
- 发明人: GRAY, Nathanael S. , HATCHER, John , CHOI, Hwan, Geun
- 申请人： Dana Farber Cancer Institute, Inc.
- 申请人地址： US Boston, Massachusetts 02215-5450 450 Brookline Avenue
- 代理机构： Haseltine Lake Kempner LLP
- 优先权： US201562116038 P 20150213
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D473/18 ; A61K31/519 ; A61P25/28
摘要：
Compounds having the formula I, II, or III:
are provided. Compounds of the present disclosure are useful for the treatment of neurodegenerative diseases, such as Parkinson's Disease.
are provided. Compounds of the present disclosure are useful for the treatment of neurodegenerative diseases, such as Parkinson's Disease.
公开/授权文献
- EP3778605A3 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME 公开/授权日：2021-03-10
信息查询
